A detailed history of Perkins Capital Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Perkins Capital Management Inc holds 40,109 shares of PFE stock, worth $1.1 Million. This represents 1.14% of its overall portfolio holdings.

Number of Shares
40,109
Previous 45,675 12.19%
Holding current value
$1.1 Million
Previous $1.28 Million 9.16%
% of portfolio
1.14%
Previous 1.26%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$27.7 - $31.39 $154,178 - $174,716
-5,566 Reduced 12.19%
40,109 $1.16 Million
Q2 2024

Aug 09, 2024

SELL
$25.26 - $29.6 $1,667 - $1,953
-66 Reduced 0.14%
45,675 $1.28 Million
Q4 2023

Jan 22, 2024

SELL
$26.13 - $33.94 $65,325 - $84,850
-2,500 Reduced 5.18%
45,741 $1.32 Million
Q3 2023

Nov 02, 2023

SELL
$32.09 - $37.51 $3,209 - $3,751
-100 Reduced 0.21%
48,241 $1.6 Million
Q2 2023

Jul 21, 2023

SELL
$36.12 - $41.79 $36,120 - $41,790
-1,000 Reduced 2.03%
48,341 $1.77 Million
Q1 2023

May 09, 2023

SELL
$39.39 - $51.28 $42,344 - $55,126
-1,075 Reduced 2.13%
49,341 $2.01 Million
Q4 2022

Jan 26, 2023

SELL
$41.75 - $54.5 $33,400 - $43,600
-800 Reduced 1.56%
50,416 $2.58 Million
Q3 2022

Oct 24, 2022

SELL
$43.76 - $53.42 $79,074 - $96,529
-1,807 Reduced 3.41%
51,216 $2.24 Million
Q2 2022

Jul 29, 2022

SELL
$46.53 - $55.17 $11,632 - $13,792
-250 Reduced 0.47%
53,023 $2.78 Million
Q1 2022

Apr 20, 2022

SELL
$45.75 - $56.69 $44,606 - $55,272
-975 Reduced 1.8%
53,273 $2.76 Million
Q4 2021

Feb 10, 2022

SELL
$41.32 - $61.25 $2,066 - $3,062
-50 Reduced 0.09%
54,248 $3.2 Million
Q3 2021

Oct 25, 2021

BUY
$39.25 - $50.42 $135,412 - $173,949
3,450 Added 6.78%
54,298 $2.34 Million
Q2 2021

Jul 28, 2021

BUY
$35.91 - $40.68 $68,947 - $78,105
1,920 Added 3.92%
50,848 $1.99 Million
Q1 2021

Apr 28, 2021

SELL
$33.49 - $37.77 $20,763 - $23,417
-620 Reduced 1.25%
48,928 $1.77 Million
Q4 2020

Feb 09, 2021

BUY
$33.47 - $42.56 $39,327 - $50,008
1,175 Added 2.43%
49,548 $1.82 Million
Q3 2020

Oct 28, 2020

SELL
$31.75 - $37.25 $123,031 - $144,343
-3,875 Reduced 7.42%
48,373 $1.78 Million
Q1 2020

Apr 29, 2020

BUY
$27.03 - $38.62 $2,919 - $4,170
108 Added 0.21%
52,248 $1.71 Million
Q4 2019

Feb 03, 2020

SELL
$32.92 - $37.36 $207,396 - $235,368
-6,300 Reduced 10.78%
52,140 $2.04 Million
Q3 2019

Oct 23, 2019

BUY
$32.49 - $42.13 $16,245 - $21,065
500 Added 0.86%
58,440 $2.1 Million
Q2 2019

Aug 09, 2019

SELL
$36.98 - $41.52 $55,802 - $62,653
-1,509 Reduced 2.54%
57,940 $2.51 Million
Q1 2019

Apr 22, 2019

SELL
$37.5 - $41.2 $284,437 - $312,502
-7,585 Reduced 11.32%
59,449 $2.53 Million
Q4 2018

Feb 11, 2019

SELL
$38.47 - $43.86 $20,581 - $23,465
-535 Reduced 0.79%
67,034 $2.93 Million
Q3 2018

Oct 22, 2018

BUY
$34.47 - $41.81 $13,788 - $16,724
400 Added 0.6%
67,569 $2.98 Million
Q2 2018

Aug 02, 2018

BUY
$32.98 - $35.16 $89,045 - $94,931
2,700 Added 4.19%
67,169 $2.44 Million
Q1 2018

Apr 23, 2018

BUY
$31.91 - $37.02 $208,531 - $241,925
6,535 Added 11.28%
64,469 $2.29 Million
Q4 2017

Jan 26, 2018

BUY
$33.26 - $35.29 $199,560 - $211,740
6,000 Added 11.55%
57,934 $2.1 Million
Q3 2017

Oct 31, 2017

BUY
$31.0 - $34.15 $1.61 Million - $1.77 Million
51,934
51,934 $1.85 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Perkins Capital Management Inc Portfolio

Follow Perkins Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Capital Management Inc with notifications on news.